ClosedPublished 18 Apr 2025

Biogen /
Nightstar Therapeutics, Inc.

Biogen acquired Nightstar Therapeutics, Inc., a gene therapy company

Buy side: Biogen
Buy sideBiogen
Target: Nightstar Therapeutics, Inc.
TargetNightstar Therapeutics, Inc.
Source · 18 Apr 2025Source-verified
Buy side: Biogen
Buy sideBiogen
Target: Nightstar Therapeutics, Inc.
TargetNightstar Therapeutics, Inc.
01 / BuyerBiogen
02 / TargetNightstar Therapeutics, Inc.
Source-verified
01

What happened

Biogen acquired Nightstar Therapeutics, Inc. in 2019. Nightstar Therapeutics, Inc. specialized in treatment of inherited retinal disease.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Biogen acquired Nightstar Therapeutics, Inc., a gene therapy company

This document is the source for the companies, stage and people on this page.

Source-verified
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.